Ralf Kircheis
Saal, NW 93342, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2.
Journal: International journal of molecular sciences
Published: March 16, 2026
Editorial: Community series in the role of toll-like receptors and their related signaling pathways in viral infection and inflammation, volume II.
Journal: Frontiers in immunology
Published: October 03, 2024
Special Issue "The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0".
Journal: International journal of molecular sciences
Published: August 30, 2024
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants.
Journal: International journal of molecular sciences
Published: March 27, 2024
Editorial: The role of toll-like receptors and their related signaling pathways in viral infection and inflammation.
Journal: Frontiers in immunology
Published: December 31, 2023
The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation.
Journal: International journal of molecular sciences
Published: March 26, 2023
Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?
Journal: International journal of molecular sciences
Published: May 02, 2022
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.
Journal: International journal of molecular sciences
Published: September 08, 2021
COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway.
Journal: Viruses
Published: August 15, 2021
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.
Journal: Frontiers in immunology
Published: August 24, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026